Small molecules that can safely induce Hsp27 or broadly enhance small Hsp activity under physiological conditions show significant promise as therapeutics for neurodegenerative diseases and for promoting nerve regeneration. The gene discussed is HSPB2; the disease is neurodegenerative disease.